Treatment of high stress Mental and Behavioural Disorders
Conditions
Interventions
1. Intervention: This intervention is designed as a recovery-based intervention. It involves direct engagement with nature, specifically forest environments, through activities tailored to participant
while the guide encourages participation, none of the activities is ever mandatory.
• Each session will begin with an introductory activity to foster initial contact among participants
• Followed by
Sponsors
Universitat Autònoma de Barcelona
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Between the ages of 18 – 75 years 2. Comply with eligibility criteria to access and take part in the evaluated intervention 3. Stress interference in daily life being significantly or very significantly (as assessed by the screening questionnaire) 4. Either: often or very often experiences of discrimination or prejudices in daily life OR Yes-experiencing persistent poor sleep quality/poor mood/low energy levels/sadness/fatigue/anxiety (as assessed by the screening questionnaire) 5. No previous (last year) or current participation in the same type of nature-based therapy we are evaluating
Exclusion criteria
Exclusion criteria: 1. Intellectual disability (ICD-11 6A00) 2. Phobias that can highly impact the capacity to benefit from our evaluated interventions, such as social and insect-related phobias (ICD-11 6B02, 6B03, 6B04) 3. Dissociative behaviors (ICD-11 6B60, 6B61, 6B62, 6B63, 6B64, 6B65, 6B66, 6E65, 6B6Y, 6B6Z) 4. Mental or behavioral symptoms, signs or clinical findings that can highly impact the capacity of the intervention group to benefit from our evaluated interventions or that increases their potential to become difficult cases to handle by guides (ICD-11 MB23.0, MB23.R, MB23.S)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Perceived stress is measured using the Perceived Stress Scale 10 items (PSS-10) at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group 2. Quality of life is measured using EuroQol 5 Dimensions 5 levels (EQ-5D-5L) at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group 3. Wellbeing is measured using ONS-4 at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Anxiety is measured using Generalized Anxiety Disorder-7 (GAD-7) at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group 2. Sleep quality is measured using PSQI-2 at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group 3. Emotional regulation is measured using Difficulties in Emotion Regulation Scale (DERS-16) at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group 4. Self-esteem is measured using Rosenberg Self-esteem Questionnaire (RSES) at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group 5. Depression is measured using Patient Health Questionnaire-9 (PHQ-9) at Screening/Baseline, 10 weeks, 14 weeks, and 22 weeks for the intervention group and at Screening/Baseline, 10 weeks, 20 weeks, and 24 weeks for the waitlist group | — |
Countries
Spain
Contacts
Public ContactMargarita Triguero-Mas
Outcome results
None listed